A regulatory framework is in place for additional Rx-to-OTC switches where appropriate, including the opioid overdose antidote naloxone. It is up to sponsors to work with the FDA to deliver more switched products.
Bold Rx-To-OTC Switches On The Horizon? Naloxone, Perhaps
